$9.99
0.323.31%
At Close: -
$10.05
0.060.60%
After Hours: Sep 20, 4:01 PM EDT
15 minutes delayed
Foghorn Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Foghorn Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.45 | $-0.65 | 30.8 % |
Mar 2024 | 2024-05-06 | $-0.59 | $-0.63 | 6.35 % |
Dec 2023 | 2024-03-07 | $-0.57 | $-0.76 | 25.0 % |
Sep 2023 | 2023-11-02 | $-0.34 | $-0.75 | 54.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $6.89M | $6.04M | 14.0 % |
Mar 2024 | 2024-05-06 | $5.05M | $6.91M | -26.9 % |
Dec 2023 | 2024-03-07 | $5.77M | $4.62M | 24.9 % |
Sep 2023 | 2023-11-02 | $17.48M | $4.52M | 286.7 % |
Foghorn Therapeutics (FHTX) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.45, which beat the estimate of $-0.65.
The Actual Revenue was $6.9M, which beat the estimate of $6M.
Browse earnings estimates, EPS, and revenue on all stocks.